Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Gynecologic 1Gastrointestinal 1

Conditions

Weight Loss 1Ovarian Neoplasms 1Osteochondroma 1Obesity 1Non-alcoholic Fatty Liver Disease 1Nevus, Epithelioid and Spindle Cell 1Malnutrition 1Lung Neoplasms 1Hematologic Neoplasms 1Glioblastoma 1Giant Cell Tumors 1Gastrointestinal Neoplasms 1Fibrosis 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Carcinoma, Lobular 1Carcinoma in Situ 1Barrett Esophagus 1

Interventions

Magnetic Resonance Spectroscopy 3Blood Specimen Collection 3Specimen Handling 2Simvastatin 2Liver Transplantation 2tremelimumab 1sofosbuvir-velpatasvir drug combination 1epigallocatechin gallate 1durvalumab 1atezolizumab 1apixaban 1User-Centered Design 1Tocopherols 1Surveys and Questionnaires 1Standard of Care 1Sodium Chloride 1Sampling Studies 1Radiotherapy 1Radiation 1Pravastatin 1Phlebotomy 1Pharmaceutical Preparations 1Pentoxifylline 1Patient Navigation 1Neuropsychological Tests 1Musculoskeletal Manipulations 1Memantine 1Losartan 1Ketoprofen 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosis × Sampling Studies × 1 year × Clear all
NCT05463796 2025-08-07

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Dana-Farber Cancer Institute

Recruiting
5,000 enrolled
GastrointestinalGynecologicOther hematologic neoplasmThoracic

Barrett Esophagus, Carcinoma in Situ, Endometrial Hyperplasia, Fibrosis, Giant Cell Tumors, Lung Neoplasms, Osteochondroma, Carcinoma, Lobular, Nevus, Epithelioid and Spindle Cell, Hematologic Neoplasms, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡